tradingkey.logo

Catheter Precision Inc

VTAK
查看详细走势图
1.770USD
-0.040-2.21%
收盘 12/24, 13:00美东报价延迟15分钟
2.92M总市值
0.05市盈率 TTM

Catheter Precision Inc

1.770
-0.040-2.21%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.21%

5天

-19.55%

1月

-4.12%

6月

-62.51%

今年开始到现在

-79.34%

1年

-75.35%

查看详细走势图

TradingKey Catheter Precision Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Catheter Precision Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名154/206位。机构持股占比非常高,近一月多位分析师给出公司评级为。最高目标价38.00。中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Catheter Precision Inc评分

相关信息

行业排名
154 / 206
全市场排名
466 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
38.000
目标均价
+1753.66%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Catheter Precision Inc亮点

亮点风险
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
业绩高增长
公司营业收入稳步增长,连续3年增长2900.00%
业绩增长期
公司处于发展阶段,最新年度总收入420.00K美元
估值高估
公司最新PE估值0.05,处于3年历史高位
机构减仓
最新机构持股24.65K股,环比减少29.05%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值0.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.33

Catheter Precision Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Catheter Precision Inc简介

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
公司代码VTAK
公司Catheter Precision Inc
CEOJenkins (David A)
网址https://www.ramed.com/

常见问题

Catheter Precision Inc(VTAK)的当前股价是多少?

Catheter Precision Inc(VTAK)的当前股价是 1.770。

Catheter Precision Inc的股票代码是什么?

Catheter Precision Inc的股票代码是VTAK。

Catheter Precision Inc股票的52周最高点是多少?

Catheter Precision Inc股票的52周最高点是15.681。

Catheter Precision Inc股票的52周最低点是多少?

Catheter Precision Inc股票的52周最低点是1.492。

Catheter Precision Inc的市值是多少?

Catheter Precision Inc的市值是2.92M。

Catheter Precision Inc的净利润是多少?

Catheter Precision Inc的净利润为-21.80M。

现在Catheter Precision Inc(VTAK)的股票是买入、持有还是卖出?

根据分析师评级,Catheter Precision Inc(VTAK)的总体评级为--,目标价格为38.000。

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是多少

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是36.353。
KeyAI